Skip to main content

Notice of completed evaluations – 14 December 2023

We have published 20 evaluations about the human health and environmental risks associated with the use of certain chemicals on the Australian Inventory of Industrial Chemicals (Inventory). The status of these evaluations has been updated in our Rolling Action Plan.

These evaluations are issued by the AICIS Executive Director under section 78 of the Industrial Chemicals Act 2019 and are listed below. The draft versions of these evaluation statements were open for public consultation that closed on the 27th of November 2023.

Note: Use the scroll bar located at the bottom of the table if you are viewing on a smaller screen or mobile device.

IDSubject of evaluationCAS numberPublic comment receivedPublic consultation outcomeEvaluation outcome
EVA00121Acetoin, cinnamaldehyde, diethylene glycol and ethylene glycol with end use in non-nicotine e-cigarettes (vaping products)104-55-2, 107-21-1, 111-46-6, 513-86-0No-Recommendation to regulatory body (public health)
EVA001231-Propanesulfonic acid, 2-hydroxy-3-(2-propenyloxy)-, monosodium salt52556-42-0No-Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA001241-Propene, 3-chloro-2-methyl-563-47-3No-Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA001252-Butanone, oxime (MEKO)96-29-7No (factual correction)A variation to the evaluation statement was required to clarify that an update to the Hazardous Chemical Information System (HCIS) is recommended.Recommendation to regulatory body (public health); Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA001272-Methoxyethyl methacrylate and 2-ethoxyethyl methacrylate6976-93-8, 2370-63-0Yes - otherA variation to the evaluation statement was not required. The proposed means of managing the risks associated with the use of these chemicals were considered to be the most risk proportionate recommendations.Proposal to vary terms of the Inventory; Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA001282-Propenamide, N,N'-methylenebis- (N,N'-methylenebisacrylamide)110-26-9No-Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA001292-Propenoic acid, 2-methyl-, 2-ethylhexyl ester (ethylhexyl methacrylate)688-84-6No-Information relating to safe introduction and use
EVA00132Alkoxysilanes substituted with 2-ethoxyethanol18407-94-8, 61667-41-2No-Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA00133Benzenamine, N-phenyl-122-39-4YesA variation to the evaluation statement was not required. The chemical is correctly classified as Carcinogen, Category 1B based on the strength and weight of evidence, and the carcinogenicity seen in animal studies.Recommendation to regulatory body (public health); Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA00134Benzene, 1-methoxy-4-nitro-100-17-4No-Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA00137Chlorendic acid and chlorendic anhydride115-27-5, 115-28-6No-Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA00138Chemicals not considered for in depth evaluation – Not commercially active in AustraliaSee evaluation statementYes - otherA variation to the evaluation statement was not required. The Evaluations Roadmap outlines our approach to evaluating the use and introduction of industrial chemicals, including chemicals that are likely not to be commercially active in Australia. If additional information becomes available we may initiate an evaluation of one or more of these chemicals.No new means of managing risk are proposed
EVA00139Chemicals that are unlikely to require further regulation to manage risks to environmentSee evaluation statementNo-No new means of managing risk are proposed
EVA00140Chemicals that are unlikely to require further regulation to manage risks to human healthSee evaluation statementNo-No new means of managing risk are proposed
EVA00142Cyclohexanamine, 4,4'-methylenebis-1761-71-3No-Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA00144Fluorescent Brightener 71 and related chemicals16090-02-1, 16470-24-9, 4193-55-9No (factual correction)A variation to the evaluation statement was required. The evaluation statement has been amended to replace “Not Persistent” with the “Persistent” classification for the chemical, Fluorescent Brightener (FB) 71 (CAS RN 16090-02-1). This amendment was based on a ready biodegradability screening test, which was reported to be inaccurate due to an invalid inoculum source.No new means of managing risk are proposed
EVA00145Glycidyl neodecanoate and glycidyl tert-decanoate26761-45-5, 71206-09-2No-Recommendation to regulatory body (workers); Information relating to safe introduction and use
EVA00148Morpholine, 4-(1-oxo-2-propenyl)- (acryloyl morpholine)5117-12-4No-Recommendation to regulatory body (public health); Information relating to safe introduction and use
EVA00149Hydroxymethylated imidazolidinones6440-58-0, 116-25-6, 136-84-5, 16228-00-5, 20662-57-1, 39236-46-9, 68411-81-4, 78491-02-8, 1854-26-8, 5395-50-6No-No new means of managing risk are proposed
EVA00152Tetrahydrofurfuryl acrylate and tetrahydrofurfuryl methacrylate2399-48-6, 2455-24-5No-Recommendation to regulatory body (public health); Recommendation to regulatory body (workers); Information relating to safe introduction and use
Published date
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Keep informed with updates